EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Soluble ST2 in Patients with Carotid Artery Stenosis—Association with Plaque Morphology and Long-Term Outcome

Stefan Stojkovic iD, Stephanie Kampf, Olesya Harkot, Maja Nackenhorst, Mira Brekalo, Kurt Huber, Christian Hengstenberg iD, Christoph Neumayer iD, Johann Wojta, Svitlana Demyanets iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24109007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Stefan Stojkovic und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Carotid Stenosis, Coronary Artery Disease, Atherosclerosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin (IL-33) and the ST2 receptor are implicated in the pathogenesis of atherosclerosis. Soluble ST2 (sST2), which negatively regulates IL-33 signaling, is an established biomarker in coronary artery disease and heart failure. Here we aimed to investigate the association of sST2 with carotid atherosclerotic plaque morphology, symptom presentation, and the prognostic value of sST2 in patients undergoing carotid endarterectomy. A total of 170 consecutive patients with high-grade asymptomatic or symptomatic carotid artery stenosis undergoing carotid endarterectomy were included in the study. The patients were followed up for 10 years, and the primary endpoint was defined as a composite of adverse cardiovascular events and cardiovascular mortality, with all-cause mortality as the secondary endpoint. The baseline sST2 showed no association with carotid plaque morphology assessed using carotid duplex ultrasound (B 0.051, 95% CI −0.145–0.248, p = 0.609), nor with modified histological AHA classification based on morphological description following surgery (B −0.032, 95% CI −0.194–0.130, p = 0.698). Furthermore, sST2 was not associated with baseline clinical symptoms (B −0.105, 95% CI −0.432–0.214, p = 0.517). On the other hand, sST2 was an independent predictor for long-term adverse cardiovascular events after adjustment for age, sex, and coronary artery disease (HR 1.4, 95% CI 1.0–2.4, p = 0.048), but not for all-cause mortality (HR 1.2, 95% CI 0.8–1.7, p = 0.301). Patients with high baseline sST2 levels had a significantly higher adverse cardiovascular event rate as compared to patients with lower sST2 (log-rank p < 0.001). Although IL-33 and ST2 play a role in the pathogenesis of atherosclerosis, sST2 is not associated with carotid plaque morphology. However, sST2 is an excellent prognostic marker for long-term adverse cardiovascular outcomes in patients with high-grade carotid artery stenosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AtheroscleroticCarotid StenosisCoronary Artery DiseaseAtherosclerosisHumansInterleukin-33Interleukin-1 Receptor-Like 1 ProteinBiomarkers

Stichwörter der Autor:innen

carotid artery diseaseprognostic biomarkersoluble suppression of tumorigenesis 2 (sST2)

Substanzen

Interleukin-33Interleukin-1 Receptor-Like 1 ProteinBiomarkers

Autor:innen und Institutionen

  • Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.
  • Department of General Surgery, Division of Vascular Surgery, Medical University of Vienna, 1090 Vienna, Austria.
  • Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
  • 3rd Medical Department with Cardiology and Intensive Care Medicine, Klinik Ottakring, 1160 Vienna, Austria.
  • Medical School, Sigmund Freud University, 1020 Vienna, Austria.
  • Ludwig Boltzmann Institute for Cardiovascular Research, 1090 Vienna, Austria.

ORCID-Profile: Stefan Stojkovic, Christian Hengstenberg, Christoph Neumayer, Svitlana Demyanets

Zitieren

APA

Stojkovic, S., Kampf, S., Harkot, O., Nackenhorst, M., Brekalo, M., Huber, K., Hengstenberg, C., Neumayer, C., Wojta, J., & Demyanets, S. (2023). Soluble ST2 in Patients with Carotid Artery Stenosis—Association with Plaque Morphology and Long-Term Outcome. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24109007

Vancouver

Stojkovic S, Kampf S, Harkot O, Nackenhorst M, Brekalo M, Huber K, et al. Soluble ST2 in Patients with Carotid Artery Stenosis—Association with Plaque Morphology and Long-Term Outcome. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24109007

BibTeX
@article{Stojkovic2023,
  author = {Stojkovic, Stefan and Kampf, Stephanie and Harkot, Olesya and Nackenhorst, Maja and Brekalo, Mira and Huber, Kurt and Hengstenberg, Christian and Neumayer, Christoph and Wojta, Johann and Demyanets, Svitlana},
  title = {Soluble ST2 in Patients with Carotid Artery Stenosis—Association with Plaque Morphology and Long-Term Outcome},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24109007}
}
Kostenlos starten →